Home>Industry update>Company news>Plexus provides rapid ventilator production

Plexus provides rapid ventilator production

08 April 2020

Products realisation company Plexus is participating in the UK government’s efforts to expedite the manufacturing of ventilators in aide of the fight against COVID-19.

Plexus will be manufacturing and delivering ventilators to the National Health Service (NHS) to assist in the treatment of COVID-19 patients.  These ventilators will be produced in Plexus’ facility located in Kelso, Scotland.

Ronnie Darroch, executive vice president and regional president - EMEA, commented: “We are proud to be a part of this opportunity to produce a substantial number of ventilators that will be deployed in hospitals across the United Kingdom. I am humbled by the incredible work ethic of the Plexus teams in Kelso and Livingston, Scotland, and around the globe, who are doing their utmost to make the rapid production of these critical products possible. I also would like to thank the courageous medical professionals of the NHS who we are honoured to serve.”

Todd Kelsey, President and CEO, added: “Plexus is uniquely qualified to support the design, development and production of critical medical equipment that assists healthcare workers in the fight against COVID-19. In addition to producing ventilators, Plexus also manufactures several other essential medical devices that further the fight against COVID-19 in its facilities around the world. These devices include: infusion pumps, diagnostic equipment, patient monitors, bronchoscopes and laryngoscopes, CT scanners, MRI machines, ultrasounds and mobile x-ray units.”

Mr. Kelsey concluded: “I applaud our team members, particularly those in our manufacturing sites, who every day are demonstrating their courage and unwavering support of our customers and the brave medical professionals around the globe. Our teams’ contributions throughout Plexus provide us the opportunity to directly and indirectly support the fight against COVID-19, while also contributing to the supply of those products that are essential and in dire need.”